Literature DB >> 12712087

Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps.

Luca Savelli1, Pierandrea De Iaco, Donatella Santini, Federica Rosati, Tullio Ghi, Elettra Pignotti, Luciano Bovicelli.   

Abstract

OBJECTIVE: The purpose of this study was to determine the rate of benign, hyperplastic, and malignant endometrial polyps and whether clinical data can predict histopathologic outcome. STUDY
DESIGN: Five hundred nine patients with endometrial polyps who consecutively underwent hysteroscopic removal of endometrial polyps over 48 months were identified from our gynecologic oncology surgical database. Medical reports provided clinical data. Statistical analysis was performed.
RESULTS: Histologically, 358 polyps (70.3%) were benign; 131 polyps (25.7%) had simple or complex endometrial hyperplasia, 16 polyps (3.1%) had hyperplasia with atypia, and 4 polyps (0.8%) were cancerous. Polyps were divided into group A and group B, according to the risk of malignancy (group A, benign; group B, atypical hyperplastic and cancerous). Age, menopause status, and hypertension were associated significantly with group B.
CONCLUSION: Endometrial polyps rarely become malignant, but hyperplastic changes are more common. Age, menopause status, and hypertension may increase the risk of premalignant and malignant polyps. To achieve complete removal of the polyp and a reliable histologic analysis, operative hysteroscopy should be offered to symptomatic patients or to patients with risk factors.

Entities:  

Mesh:

Year:  2003        PMID: 12712087     DOI: 10.1067/mob.2003.247

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  18 in total

1.  The value of hysteroscopic biopsy in the diagnosis of endometrial polyps.

Authors:  Daniel Spadoto-Dias; Flávia Neves Bueloni-Dias; Leonardo Vieira Elias; Nilton José Leite; Waldir Pereira Modotti; Ricardo Bassil Lasmar; Rogério Dias
Journal:  Womens Health (Lond)       Date:  2016-07

2.  Utility of a standardized protocol for submitting clinically suspected endometrial polyps to the pathology laboratory.

Authors:  Nida S Safdar; Giovanna A Giannico; Mohamed Mokhtar Desouki
Journal:  Ann Diagn Pathol       Date:  2016-05-18       Impact factor: 2.090

3.  History of uterine leiomyoma and risk of endometrial cancer in black women.

Authors:  Lauren A Wise; Todd R Sponholtz; Lynn Rosenberg; Lucile L Adams-Campbell; Wendy Kuohung; Michael P LaValley; Julie R Palmer
Journal:  Cancer Causes Control       Date:  2016-02-29       Impact factor: 2.506

4.  Microsatellite instability in endometrial polyps.

Authors:  Salete S Rios; Rosângela V Andrade; Rinaldo W Pereira; Nathan R Wall; Khaled Bahjri; Érica Caldas; Larissa Cavalcante; Florêncio Figueiredo
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2010-08-11       Impact factor: 2.435

5.  Risk Factors Associated with the Malignant Changes of Symptomatic and Asymptomatic Endometrial Polyps in Premenopausal Women.

Authors:  Amr K Elfayomy; Badeea S Soliman
Journal:  J Obstet Gynaecol India       Date:  2014-06-01

6.  History of uterine leiomyomata and incidence of breast cancer.

Authors:  Lauren A Wise; Rose G Radin; Lynn Rosenberg; Lucile Adams-Campbell; Julie R Palmer
Journal:  Cancer Causes Control       Date:  2015-08-07       Impact factor: 2.506

7.  Thickness of preperitoneal fat as a predictor of malignancy in overweight and obese women with endometrial polyps.

Authors:  Andrea Ciavattini; Jacopo DI Giuseppe; Nicolò Clemente; Lorenzo Moriconi; Giovanni Delli Carpini; Nina Montik; Laura Mazzanti
Journal:  Oncol Lett       Date:  2016-02-04       Impact factor: 2.967

8.  Sox9 overexpression in uterine epithelia induces endometrial gland hyperplasia.

Authors:  Gabriel Gonzalez; Shyamin Mehra; Ying Wang; Haruhiko Akiyama; Richard R Behringer
Journal:  Differentiation       Date:  2016-06-01       Impact factor: 3.880

9.  Translocation of vaginal microbiota is involved in impairment and protection of uterine health.

Authors:  Jinfeng Wang; Zhanzhan Li; Xiuling Ma; Lifeng Du; Zhen Jia; Xue Cui; Liqun Yu; Jing Yang; Liwen Xiao; Bing Zhang; Huimin Fan; Fangqing Zhao
Journal:  Nat Commun       Date:  2021-07-07       Impact factor: 14.919

10.  Which patients on a gynecologic oncology service will require perioperative transfusion? A single-center retrospective cohort study.

Authors:  Gregory W Kirschen; Samantha M Dayton; Sophia Blakey-Cheung; Michael L Pearl
Journal:  Clin Exp Obstet Gynecol       Date:  2021-02-15       Impact factor: 0.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.